Loading...
NPI 1992048391 · East Meadow, NY · Vascular & Interventional Radiology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Michael Drabkin is a vascular & interventional radiology physician provider located in East Meadow, New York. This profile covers 45 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Michael Drabkin |
| Address | 2201 Hempstead Tpke |
| City | East Meadow |
| State | NY |
| ZIP | 11554 |
| Taxonomy | Vascular & Interventional Radiology Physician |
| NPI Enumerated | April 3, 2013 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.1M |
| Medicaid | $1.8K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
45 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 37243 | The physician partially or completely blocks vascular blood flow in the target area for benign or malignant tumors (including uterine fibroids), organ ischemia, or infarction. | 70 | $8,590 | $575.6K |
| 36561 | A central venous access catheter is a device that the physician inserts beneath the skin to draw blood or administer medication/nutrients to the patient. The catheter's tip must terminate in the… | 110 | $960 | $107K |
| 36247 | Angiography is an X–ray study of the blood vessels that helps physicians diagnose and treat medical conditions. Angiography uses a radiopaque substance (dye) to make the blood vessels visible under… | 70 | $860 | $58.3K |
| 36245 | Angiography is an X–ray study of the blood vessels that helps physicians diagnose and treat medical conditions. Angiography uses a radiopaque substance (dye) to make the blood vessels visible under… | 70 | $740 | $50.4K |
| 36246 | Angiography is an X–ray study of the blood vessels that helps physicians diagnose and treat medical conditions. Angiography uses a radiopaque substance (dye) to make the blood vessels visible under… | 70 | $500 | $33.9K |
| 49083 | In this procedure, the provider withdraws an abnormal buildup of fluid from the abdominal cavity to relieve pressure and pain or to obtain a sample to submit to a laboratory for analysis. He… | 110 | $280 | $30.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 160 | $170 | $25.9K |
| 77012 | In this procedure, the provider performs supervision and interpretation for a separately reportable procedure that uses computed tomography guided needle placement, as in biopsy or aspiration. Report… | 180 | $140 | $24.7K |
| 38222 | The provider takes a scraping or sample of bone marrow tissue, using biopsy and aspiration techniques, for diagnostic purposes. Bone marrow aspiration is typically performed prior to the biopsy when… | 150 | $160 | $23.6K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 920 | $20 | $21.2K |
Showing 1–10 of 45
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 45 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
45 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 37243 | 4 | 20 | 30 | $4,060 | $146.1K |
| 88185 | 59 | 100 | 1,210 | $20 | $74.9K |
| 99214 | 13,785 | 30,450 | 90 | $100 | $19K |
| 72197 | 350 | 360 | 50 | $190 | $16.9K |
| 36247 | 6 | 60 | 30 | $420 | $15.1K |
| 99213 | 27,041 | 31,440 | 80 | $70 | $12.1K |
| 77002 | 213 | 310 | 30 | $100 | $10.9K |
| 88184 | 60 | 100 | 60 | $70 | $10.7K |
| 99215 | 917 | 8,280 | 40 | $140 | $10.1K |
| 36245 | 2 | 20 | 20 | $360 | $9.5K |
Showing 1–10 of 45
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 77012 | In this procedure, the provider performs supervision and interpretation for a separately reportable procedure that uses computed tomography guided needle placement, as in biopsy or aspiration. Report… | 30 | $30 | $900 |
| 38222 | The provider takes a scraping or sample of bone marrow tissue, using biopsy and aspiration techniques, for diagnostic purposes. Bone marrow aspiration is typically performed prior to the biopsy when… | 20 | $30 | $700 |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 10 | $20 | $230 |
| J0690 | Injection, cefazolin sodium, 500 mg | 20 | $1 | $20 |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 424 | 430 | 680 | $120 | $299.9K |
| 38222 | The provider takes a scraping or sample of bone marrow tissue, using biopsy and aspiration techniques, for diagnostic purposes. Bone marrow aspiration is typically performed prior to the biopsy when… | 7 | 10 | 50 | $420 | $133.7K |
| 77012 | In this procedure, the provider performs supervision and interpretation for a separately reportable procedure that uses computed tomography guided needle placement, as in biopsy or aspiration. Report… | 3 | 10 | 30 | $140 | $5.4K |
| J0690 | Injection, cefazolin sodium, 500 mg | 151 | 160 | 1,250 | $1 | $2.2K |
Other providers in the same ZIP code as Michael Drabkin, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Nassau Health Care Corporation | NY | General Acute Care Hospital | $0 | $42.1M |
| Sports Physical Therapy Occupational Therapy And Rehabilitation Servic | NY | Hand Physical Therapist | $0 | $25.4M |
| County Of Nassau County Controller | NY | Mental Health Clinic/Center (Including Community Mental Health Center) | $344.6K | $8.4M |
| Christopher Calapai | NY | Family Medicine Physician | $1.9M | $380 |
| Jay Purvin | NY | Podiatrist | $345.3K | $178K |
| Jason Lipetz | NY | Pain Medicine (Physical Medicine & Rehabilitation) Physician | $466.3K | $0 |
| Albert Ferrara | NY | Internal Medicine Physician | $422.6K | $21.1K |
| Genia Bekker | NY | Obstetrics & Gynecology Physician | $283.9K | $100K |
| Michael Schwartz | NY | Sports Medicine (Orthopaedic Surgery) Physician | $343.4K | $0 |
| Faina Akselrod | NY | Obstetrics & Gynecology Physician | $302.9K | $39.3K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.